國瑞置業(02329.HK):完成2024年到期的14.25釐優先票據的交換要約及同意徵求
格隆匯2月28日丨國瑞置業(02329.HK)發佈公吿,截至該公吿日期,交換要約及同意徵求的所有先決條件已獲達成,而交換要約及同意徵求亦已完成。因此,根據交換要約及同意徵求而有效交出以進行交換(並視為已就建議修訂作出同意)及獲接納的現有票據均已註銷。截至該公吿日期,本金總額為858.6萬美元的現有票據仍存續。
作為交換要約及同意徵求的一部分,本金總額為3.3479億美元的新票據於2022年2月23日獲發行,並將於2024年8月23日到期,除非根據其條款提前贖回。新票據將自2022年2月23日起計息,自2022年8月23日起須於每年的2月23日及8月23日每半年支付一次。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.